CNBCTV184d
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' events
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in US
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Dr Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy’s recalls mislabelled seizure injection Levetiracetam in U.S. to consumer level
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
The free‑living bureaucrat
Michael Lewis is the author, most recently, of “Going Infinite: The Rise and Fall of a New Tycoon.” His other works include ...
pharmaphorum1d
Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe
Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The CMA ...
pharmaphorum4d
Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid
Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...
Medscape5d
Levetiracetam for Managing Neurologic and Psychiatric Disorders
The levetiracetam dosage was increased by 500 mg twice daily at the end of weeks 2 and 4 to a maximum dosage of 1500 mg twice daily, unless the patient had been seizure free during the previous 2 ...
EurekAlert!6d
Spectroscopy technique could improve surgery for pediatric epilepsy patients
A new study demonstrates the potential of Raman spectroscopy to improve surgical outcomes for pediatric patients with focal cortical dysplasia (FCD) type II, a leading cause of drug-resistant epilepsy ...